Sulpiride decreases anterior pituitary cell proliferation <i>in vivo</i>. by Jimena Ferraris (314722)

Down-regulation of Gli decreased ovarian cancer cell migration and invasion. by Qi Chen (144168)

“…(<b>B</b>) Expression of both Gli1 and Gli2 mRNA is decreased following treatment with GANT61 (30 µM; 48 hr), determined by real-time PCR. …”

Decreased β-catenin levels in the retinas of the diabetic and OIR KO mice. by Kelu Kevin Zhou (637715)

Oligospermia and decreased fertility in <i>Chtf18</i>-null mice. by Karen M. Berkowitz (123502)

Bufalin downregulates SRC–3 and decreases cell viability in TNBC cells. by Xianzhou Song (803006)

“…<p>(A) Western blot shows that bufalin (100 nM) downregulates SRC–3 protein levels in TNBC cells. …”

Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation. by Yuping Luo (147790)

“…(E,F), Luciferase reporter assay showing that differentiating <i>Fmr1</i> KO aNPCs had decreased <i>NeuroD1</i> (E; n = 4, p<0.01), but increased GFAP (F, n = 3, p<0.05) promoter activities compared with WT aNPCs. …”

Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

“…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”

<i>Rbfox3</i> deletion decreased the thickness of the IPL in the retina. by Yi-Sian Lin (3193446)

Reduction of Tks5 expression in tumor cells is associated with decreased angiogenesis. by Barbara Blouw (715467)

JNK and ERK phosphorylation is decreased by inhibitors of Rho kinase and actin polymerization. by Hui-Ju Hsu (242886)

SUI-sEVs decreased the migration ability of primary cultured fibroblasts. by Xiaoyan Sun (28501)

Heart specific RNase Z variants show a mild decrease in longevity and locomotor response. by Ekaterina Migunova (15909887)

FSS rescues homocysteine-caused the decrease of NO production in cultured HUVECs after the application of A23187. by Cathy W. C. Bi (108697)

Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

“…<p>VCaP cells were transfected for 24h, 48h and 72h with 50 nM of siRNAs TMPRSS2-ERG III (1, 2, 3), siRNAs TMPRSS2-ERG IV (1, 2), siRNA against ERG wild type or siRNA Control. …”

The distributions of the end-simulation adolescence-limited proportion when (a) <i>k</i> is increased or decreased by 50%, (b) <i>c</i> is increased or decreased by 50%, (c) <i>γ</i> is increased or decreased by 50%, and (d) Δ<i>e</i> is increased or decreased by 50%, compared against the benchmark distribution <i>F</i>(<b>p</b>₀) for the parameters shown in Table 1. by Jia Ning Leaw (752775)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”

Effects of siRNA TMPRSS2-ERG III and IV on cell death pathways. by Giorgia Urbinati (554921)

<i>T. cruzi</i> PCM abrogates MAP kinase activation and decreased MAP kinase signaling results in inhibition of ctgf/ccn2 expression. by G. Adam Mott (198973)

NEMO knockout murine dermal fibroblasts show a decreased nuclear translocation of p65. by Patrick Meyer (3395285)

CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…(F) Increasing concentrations to 50 nM still enhances clonogenic survival of HBEC 30KT, but actually seems to decrease survival in HCC 4017 after 3 Gy radiation. …”